Treace Medical Concepts (TMCI) EBIT Margin (2020 - 2026)
Treace Medical Concepts (TMCI) posted EBIT Margin of 36.37% for Q1 2026, down 283.99% on a QoQ basis from 9.47% in Q4 2025, and down 673.0% year-over-year from 6.35% in Q1 2025.
Treace Medical Concepts (TMCI) EBIT Margin (2020 - 2026) Analysis & Trends
Treace Medical Concepts' EBIT Margin history runs 7 years deep, the most recent figure standing at 36.37% for Q1 2026.
- Quarterly EBIT Margin fell 673.0% year-over-year to 36.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 26.89% (down 208.0% YoY) and the FY2025 annual result came in at 25.46%, up 114.0% from the prior year.
- EBIT Margin was 36.37% for Q1 2026 at Treace Medical Concepts, down from 9.47% in the prior quarter.
- Across five years, EBIT Margin topped out at 0.3% in Q4 2024 and bottomed at 48.1% in Q2 2024.
- A 5-year average of 28.76% and a median of 32.65% in 2023 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2022 — EBIT Margin slumped 2038 bps — and 2025, when it soared 1228 bps.
- Treace Medical Concepts' EBIT Margin stood at 7.03% in 2022, then tumbled by 55 bps to 10.9% in 2023, then surged by 97 bps to 0.3% in 2024, then tumbled by 3090 bps to 9.47% in 2025, then slumped by 284 bps to 36.37% in 2026.
- Business Quant data shows TMCI's EBIT Margin at 36.37% in Q1 2026, 9.47% in Q4 2025, and 31.22% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | -36.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.37% |
| Dec 31, 2025 | -9.47% |
| Sep 30, 2025 | -31.22% |
| Jun 30, 2025 | -35.82% |
| Mar 31, 2025 | -29.64% |
| Dec 31, 2024 | -0.30% |
| Sep 30, 2024 | -33.57% |
| Jun 30, 2024 | -48.10% |
| Mar 31, 2024 | -37.11% |
| Dec 31, 2023 | -10.90% |
| Sep 30, 2023 | -43.72% |
| Jun 30, 2023 | -31.11% |
| Mar 31, 2023 | -32.65% |
| Dec 31, 2022 | -7.03% |
| Sep 30, 2022 | -34.24% |
| Jun 30, 2022 | -39.82% |
| Mar 31, 2022 | -27.87% |
| Dec 31, 2021 | -16.74% |
| Sep 30, 2021 | -25.26% |
| Jun 30, 2021 | -19.61% |